If you’re looking to get rid of wrinkles and fine lines, Botox’s newest competitor, Jeuveau, might be right for you. Since Botox was FDA approved back in 2002, there have been few other competitors that have entered the market and have had as much success. It’s kind of a big deal that Jeuveau was FDA approved just this year because it’s the first new brand of neurotoxin to come to the U.S. market in almost 10 years. As a medical spa, having more options for our clients is always a good thing.
How is Jeuveau different than Botox?
Jeuveau is a neurotoxin that is structurally similar to Botox. They’re even branding themselves as #NEWTOX. Both Jeuveau and Botox are used to improve the appearance of frown lines and even have identical risks and potential side effects. The biggest and most notable difference between Jeuveau and Botox is the price. Jeaveau runs slightly cheaper than Botox because it is priced at a premium. Unlike Jeuveau, Botox has medical indications, such as treating migraines and hyperhidrosis, and was used for medical purposes before it was approved for cosmetics. Jeuveau is purely cosmetic and is not subject to any insurance coverage or reimbursement, so it tends to run a little cheaper.
Is one better than the other?
We say no. Seeing as Botox and Jeuveau are both made of the same ingredients and serve the same cosmetic purpose, there is no true winner in quality of the treatment. When making the decision between the two, it all comes down to doctor recommendations and patient preference.
Where you can find Jeuveau
This month at ANU, the Jeuveau treatment is a new monthly special at a great price! For just $10 per unit, you can say goodbye to wrinkles. Book an appointment now: http://bit.ly/2ZeoKYZ
